Janney Montgomery Scott LLC Biocryst Pharmaceuticals Inc Transaction History

Janney Montgomery Scott LLC

$36.1 Billion
Q4 2024

A detailed history of Janney Montgomery Scott LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 55,125 shares of BCRX stock, worth $420,052. This represents 0.0% of its overall portfolio holdings.

Number of Shares

55,125

Previous 58,604 5.94%

Holding current value

$420,052

Previous $445,000 6.74%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 17, 2025	SELL	$7.03 - $8.43 $24,457 - $29,327	-3,479 Reduced 5.94%	55,125 $415,000
Q3 2024 Oct 29, 2024	SELL	$6.41 - $8.69 $46,312 - $62,785	-7,225 Reduced 10.98%	58,604 $445,000
Q2 2024 Jul 25, 2024	BUY	$4.13 - $6.79 $176,470 - $290,129	42,729 Added 184.97%	65,829 $407,000
Q1 2024 May 01, 2024	BUY	$4.89 - $7.65 $4,806 - $7,519	983 Added 4.44%	23,100 $117,000
Q4 2023 Feb 07, 2024	SELL	$4.98 - $6.77 $27,190 - $36,964	-5,460 Reduced 19.8%	22,117 $132,000
Q3 2023 Nov 08, 2023	BUY	$6.71 - $7.92 $4,697 - $5,544	700 Added 2.6%	27,577 $195,000
Q2 2023 Jul 26, 2023	BUY	$6.96 - $8.81 $36,609 - $46,340	5,260 Added 24.33%	26,877 $189,000
Q1 2023 Apr 28, 2023	BUY	$7.94 - $11.84 $3,573 - $5,328	450 Added 2.13%	21,617 $180,000
Q2 2022 Aug 03, 2022	SELL	$7.89 - $17.88 $31,560 - $71,520	-4,000 Reduced 15.89%	21,167 $221,000
Q4 2021 Jan 27, 2022	SELL	$11.18 - $15.46 $27,759 - $38,387	-2,483 Reduced 8.98%	25,167 $349,000
Q3 2021 Oct 29, 2021	BUY	$14.21 - $17.65 $28,420 - $35,300	2,000 Added 7.8%	27,650 $397,000
Q2 2021 Jul 26, 2021	BUY	$9.5 - $17.24 $4,750 - $8,620	500 Added 1.99%	25,650 $406,000
Q1 2021 Apr 27, 2021	SELL	$7.37 - $13.61 $30,585 - $56,481	-4,150 Reduced 14.16%	25,150 $256,000
Q4 2020 Jan 25, 2021	BUY	$3.37 - $8.61 $2,527 - $6,457	750 Added 2.63%	29,300 $218,000
Q3 2020 Nov 06, 2020	BUY	$3.43 - $5.53 $10,290 - $16,590	3,000 Added 11.74%	28,550 $98,000
Q2 2020 Jul 23, 2020	BUY	$1.9 - $5.61 $5,700 - $16,830	3,000 Added 13.3%	25,550 $122,000
Q1 2020 Apr 30, 2020	SELL	$1.6 - $4.11 $136 - $349	-85 Reduced 0.38%	22,550 $45,000
Q4 2019 Jan 21, 2020	SELL	$1.59 - $3.45 $5,088 - $11,040	-3,200 Reduced 12.39%	22,635 $78,000
Q2 2019 Jul 29, 2019	SELL	$2.91 - $9.15 $2,910 - $9,150	-1,000 Reduced 3.73%	25,835 $98,000
Q1 2019 Apr 30, 2019	SELL	$7.38 - $9.72 $2,214 - $2,916	-300 Reduced 1.11%	26,835 $218,000
Q4 2018 Feb 01, 2019	SELL	$6.51 - $9.6 $14,322 - $21,120	-2,200 Reduced 7.5%	27,135 $219,000
Q2 2018 Jul 24, 2018	BUY	$4.6 - $6.52 $2,300 - $3,260	500 Added 1.73%	29,335 $168,000
Q1 2018 Apr 19, 2018	SELL	$4.35 - $5.82 $8,265 - $11,058	-1,900 Reduced 6.18%	28,835 $138,000
Q4 2017 Feb 14, 2018	SELL	$4.16 - $5.33 $2,496 - $3,198	-600 Reduced 1.91%	30,735 $151,000
Q3 2017 Nov 15, 2017	BUY	$4.1 - $5.97 $128,473 - $187,069	31,335	31,335 $164,000

Others Institutions Holding BCRX

# of Institutions

277

Shares Held

171M

Call Options Held

625K

Put Options Held

739K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.42B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Account

Janney Montgomery Scott LLC Biocryst Pharmaceuticals Inc Transaction History